India Diagnostics Devices Market Overview
India Diagnostics Devices Market Size was valued at USD 2.1 Billion in 2022. The diagnostics devices market industry is projected to grow from USD 2.5 Billion in 2023 to USD 10.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 19.50% during the forecast period (2023 - 2032). Increasing prevalence of chronic diseases, growing awareness and focus on preventive healthcare, technological advancements, and increasing healthcare expenditure are the main market drivers anticipated to propel the diagnostics devices market in India.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Diagnostics Devices Market Trends
- Growing awareness and focus on preventive healthcare is driving the market growth
There is a growing awareness among the population about the importance of preventive healthcare. Individuals are increasingly opting for regular health check-ups and screenings to detect diseases at an early stage. This drives the demand for diagnostic devices for screening, monitoring, and early detection of diseases. There is a growing emphasis on healthy living and wellness, with individuals adopting healthier lifestyles, including regular exercise, balanced diets, and stress management. This increased health consciousness has led to a greater focus on preventive healthcare, including the use of diagnostic devices for health monitoring and early detection of potential health issues. Additionally, the growing awareness of preventive healthcare has led to an increase in the availability of screening and diagnostic services across healthcare facilities in India. Diagnostic centers, clinics, and hospitals are offering comprehensive health check-up packages and specialized screening programs to cater to the demand for preventive healthcare. This availability of services further encourages individuals to undergo regular screenings and diagnostic tests.
Furthermore, the rising burden of chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory disorders in India is driving the demand for diagnostic devices. Early and accurate diagnosis is crucial for effective disease management, leading to increased adoption of diagnostic devices. In addition, the Indian government and healthcare organizations have been actively promoting preventive healthcare through various initiatives and awareness campaigns. Programs such as National Health Mission (NHM), Ayushman Bharat, and National Non-Communicable Disease Control Program (NPCDCS) aim to raise awareness about the importance of preventive measures, including regular screenings and diagnostic tests. These initiatives contribute to increased awareness and drive the adoption of diagnostic devices.
Diagnostics Devices Market Segment Insights
Diagnostics Devices Type Insights
India Diagnostics Devices market segmentation, based on type includes Immunodiagnostics, Clinical Chemistry, Tissue Diagnostics, Haematology, Point of Care Tests, Molecular Diagnostics and Others. The immunodiagnostics segment dominated the market mostly. Immunodiagnostics involves the detection and measurement of specific antigens or antibodies in the body to diagnose and monitor various diseases, including infectious diseases, autoimmune disorders, and cancer. Immunodiagnostics is widely used for screening, diagnosis, and monitoring of diseases, contributing to its high demand in the Indian market.
Diagnostics Devices Product Type Insights
India Diagnostics Devices market segmentation, based on product type, includes Instruments/Analysers and Reagents & Kits. The instruments/analyzers category generated the most income. Diagnostic instruments/analyzers are essential tools used for the analysis and interpretation of diagnostic tests. They play a crucial role in the accurate and efficient diagnosis of various diseases and conditions. These instruments are used in hospitals, diagnostic centers, and laboratories, contributing to their high demand in the market.
Diagnostics Devices Application Insights
India Diagnostics Devices market segmentation, based on application includes Infectious Disease, Oncology, Hormone, Diabetes, Cardiac and Others. The infectious disease segment dominated the market mostly. Infectious diseases, including viral, bacterial, and parasitic infections, pose a significant healthcare burden in India. Diseases such as tuberculosis, malaria, dengue, hepatitis, and HIV/AIDS are prevalent in the country. The need for accurate and timely diagnosis of infectious diseases drives the demand for diagnostic devices in this segment.
Diagnostics Devices End User Insights
India Diagnostics Devices market segmentation, based on end user includes Diagnostic Chains, Individual Diagnostic Laboratories, Hospital Laboratories and Others. The hospital laboratories segment dominated the market mostly. Hospital laboratories typically handle a large volume of diagnostic tests due to the wide range of medical services provided in hospitals. These laboratories cater to the diagnostic needs of inpatients, outpatients, and emergency cases. The high volume of tests performed in hospital laboratories contributes to their dominance in the market.
Figure 1: India Diagnostics Devices Market, by End User, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Diagnostics Devices Country Insights
India is a rapidly growing market for diagnostics devices, driven by factors such as increasing healthcare expenditure, growing awareness about preventive healthcare, rising incidence of chronic diseases, and government initiatives to improve healthcare infrastructure. The Indian government has implemented several initiatives to improve healthcare infrastructure and access to diagnostic services. Initiatives such as Ayushman Bharat, National Health Mission (NHM), and National Non-Communicable Disease Control Program (NPCDCS) focus on preventive healthcare, early detection, and treatment of diseases, thereby driving the demand for diagnostic devices. Moreover, the private sector plays a crucial role in the India Diagnostics Devices Market, with private diagnostic chains and laboratories offering a wide range of diagnostic tests and services. These private players contribute significantly to the market growth, especially in urban areas. Also, the market is witnessing rapid technological advancements in diagnostic devices, including the integration of artificial intelligence (AI), automation, and digital health technologies. These advancements enhance the accuracy, efficiency, and accessibility of diagnostic tests, driving market growth.
Diagnostics Devices Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the diagnostics devices market grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the diagnostics devices industry must offer cost-effective items.
Major players in the diagnostics devices market are attempting to increase market demand by investing in research and development operations includes Roche Diagnostics India Private Limited; Siemens Ltd. (Siemens Healthineers India); Becton Dickinson India Pvt Ltd; Beckman Coulter India Private Limited; Abbott India; Transasia Bio-Medicals Limited; Tulip Diagnostics Pvt Ltd; Trivitron Healthcare Pvt Ltd.
Key Companies in the diagnostics devices market include
Diagnostics Devices Industry Developments
September 2021: Abbott launched its Alinity m Resp-4-Plex molecular diagnostic test, which can detect and differentiate between SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) in a single test.
July 2021: Bio-Rad Laboratories launched its QXDx AutoDG ddPCR System, a fully automated droplet digital PCR (ddPCR) system for high-throughput research and clinical laboratories.
Diagnostics Devices Market Segmentation
Diagnostics Devices Type Outlook
- Immunodiagnostics
- Clinical Chemistry
- Tissue Diagnostics
- Haematology
- Point of Care Tests
- Molecular Diagnostics
- Others
Diagnostics Devices Product Type Outlook
- Instruments/Analysers
- Reagents & Kits
Diagnostics Devices Application Outlook
- Infectious Disease
- Oncology
- Hormone
- Diabetes
- Cardiac
- Others
Diagnostics Devices End User Outlook
- Diagnostic Chains
- Individual Diagnostic Laboratories
- Hospital Laboratories
- Others
Diagnostics Devices Type Outlook
Report Attribute/Metric |
Details |
Market Size 2022 |
USD 2.1 Billion |
Market Size 2023 |
USD 2.5 Billion |
Market Size 2032 |
USD 10.4 Billion |
Compound Annual Growth Rate (CAGR) |
19.50% (2023-2032) |
Base Year |
2022 |
Market Forecast Period |
2023-2032 |
Historical Data |
2018- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Type, Product Type, Application, End User, and Region |
Countries Covered |
India |
Key Companies Profiled |
Roche Diagnostics India Private Limited; Siemens Ltd. (Siemens Healthineers India); Becton Dickinson India Pvt Ltd; Beckman Coulter India Private Limited; Abbott India; Transasia Bio-Medicals Limited; Tulip Diagnostics Pvt Ltd; Trivitron Healthcare Pvt Ltd. |
Key Market Opportunities |
·      Increasing Private Sector Participation ·      Rise in the number of new investors, and robust R&D efforts by current market participants |
Key Market Dynamics |
·      Growth in the Hospital Laboratories market ·      Growing Awareness and Focus on Preventive Healthcare |
Frequently Asked Questions (FAQ) :
India diagnostics devices market size was valued at USD 2.1 Billion in 2022.
The market is projected to grow at a CAGR of 19.50% during the forecast period, 2023-2032.
The key players in the market are Roche Diagnostics India Private Limited; Siemens Ltd. (Siemens Healthineers India); Becton Dickinson India Pvt Ltd; Beckman Coulter India Private Limited; Abbott India; Transasia Bio-Medicals Limited; Tulip Diagnostics Pvt Ltd; Trivitron Healthcare Pvt Ltd.
The instruments/analysers category dominated the market in 2022.
The hospital laboratories category had the largest share in the market.